Variantyx
Variantyx61
About
What does Variantyx do?
Variantyx is a technology-driven precision medicine company that provides state-of-the-art diagnostic solutions. Their unique, comprehensive testing platform utilizes whole genome sequencing to identify genetic variations for rare genetic disorders, reproductive genetics, and to optimize treatment in oncology, offering actionable insights for patients and clinicians.
What is Variantyx's revenue?
StartupHub estimates Variantyx's annual revenue at $40.6M (range $21.6M to $44.9M, 66% confidence), based on comparable companies in the sector.
What is Variantyx's valuation?
StartupHub estimates Variantyx's effective valuation at $314.4M (range $186.3M to $447.0M, 13% confidence), based on comparable companies in the sector.
How much funding has Variantyx raised?
Variantyx has raised a total of $75M in funding. The most recent round on record is Series D.
Where is Variantyx headquartered?
Variantyx is headquartered in Framingham, United States.
When was Variantyx founded?
Variantyx was founded in 2014.
What industry does Variantyx operate in?
Variantyx operates in Healthcare, Genomics, Sequencing, Genetics, Life Sciences, Oncology.
How many employees does Variantyx have?
Variantyx has approximately 226 people on record.
No comments yet. Be the first to share your take.